In Brief: Bryan's Sclerosol
Executive Summary
Bryan's Sclerosol: Sterile aerosol Luzenac talc "approvable" Aug. 9 for treatment of malignant pleural effusion. Sclerosol (NDA 20-587) was unanimously recommended for approval by FDA's Oncologic Drugs Advisory Committee on Dec. 14 ("The Pink Sheet" Dec. 18, 1995, T&G-6)...